SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Middle East shipping and energy-infrastructure attack concerns are driving crude higher and drawing attention to USO, which tracks WTI futures. Traders are split between bullish supply-disruption fears and bearish calls for a pullback if tensions ease, with some warning the rally is stretched.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves selloff is centered on concerns that its debt-heavy AI infrastructure buildout could become harder to finance if borrowing costs stay high or AI demand slows, amplified by bearish HSBC commentary and pressure across neocloud stocks. Traders are split between warnings of further downside and default risk, and bullish arguments that the companys backlog and AI demand support a rebound.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

A steep selloff in USAR and the broader rare-earth sector is driving discussion, with traders pointing to dilution concerns, heavy spending before large-scale production and weak sentiment around management. Some blame short selling or broader market pressure, while bulls argue the companys government backing and domestic magnet ambitions support its long-term case and see the decline as oversold.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras steep post-IPO decline is drawing attention, with traders focused on successive share-lockup expirations and reported insider selling as potential sources of supply, alongside a price-target cut and weakness in AI stocks. Bears see continued pressure from valuation and execution concerns, while bulls argue the selloff is overdone and point to the companys AI-chip technology and long-term potential.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

UBSs downgrade of NuScale to Sell, citing long commercialization timelines and a lack of firm customer commitments, is driving the selloff. Traders debate whether it signals deeper execution risks, including delays around the TVA opportunity, or overstates the concerns amid weakness across nuclear stocks; some view the decline as a buying opportunity.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicors Q3 results are driving discussion, with traders emphasizing strong revenue growth and improved margins while debating the GAAP EPS shortfall and the lack of forward guidance. Some view the AI power-delivery and licensing growth as encouraging, while others are cautious about valuation and whether the earnings news is enough to support the stock.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs quarterly earnings beat and new multiyear buyback are drawing attention, but shares are falling as traders question why the stock dropped despite the results. The debate centers on the unchanged profit-outlook midpoint and weaker vehicle sales versus the buyback and stronger cash-flow outlook.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

A sharp pullback across AI and neocloud stocks has focused attention on fears that infrastructure spending may not deliver returns and that tighter financing could pressure providers, with CoreWeaves debt concerns often cited as a sector risk. Traders are divided between buying Nebiuss rebound as an oversold dip and expecting more downside until funding and market conditions improve.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStops warrant-expiration notice is driving discussion, as traders debate whether the approaching deadline and possible dilution are weighing on shares or whether unexercised warrants would remove dilution risk. Sentiment is split between frustration with Ryan Cohen and speculation about an extension or other corporate action; those hopes remain unconfirmed.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A tech-led rebound in the Nasdaq-100 after a sharp AI-stock selloff, ahead of major technology earnings, has put QQQ in focus. Traders are split over whether the bounce can hold or is a temporary relief rally, citing concerns about AI financing, narrow market breadth and rising oil-related inflation risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement

Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist AgreementPR NewswireSACRAMENTO, Calif., Sept. 22, 2026 Exclusive worldwide agreement adds human cellular validation to...

Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI

Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AIPR NewswireSACRAMENTO, Calif., Sept. 16, 2026 5.1-fold enrichment using NIH Tox21 data validates structure-based AChE...

Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint

Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint PR Newswire WILMINGTON, Del. and SACRAMENTO, Calif., Sept. 4, 2026 Correction Updates a Reference...

Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit

Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit PR Newswire WILMINGTON, Del. and SACRAMENTO, Calif., Aug. 27, 2026 Second Amended Complaint Alleges Securities...

Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027 Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's...

Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit

Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit PR Newswire WILMINGTON, Del. and SACRAMENTO, Calif., Aug. 4, 2026 Amended Complaint Alleges 29.6 Million Failed to Deliver Shares...

LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS

LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS PR Newswire SACRAMENTO, Calif., June 17, 2026 SACRAMENTO, Calif., June 17, 2026 /PRNewswire/ -- Fellow Shareholders,Over the past several months, Lunai Bioworks (NASDAQ: LNAI) has continued to execute its strategy...

Why Did LNAI Stock Soar Over 100% In Pre-Market Trading Today?

Equity

Lunai Bioworks said Nasdaq confirmed that the company regained compliance with the exchange’s minimum bid price requirement, according to an SEC filing.

Lunai Bioworks (LNAI) Stock Is Trending Overnight  Here's Why It Spiked Nearly 81% In After-Hours Session

Lunai Bioworks Inc. shares soared 80.88% after-hours after regaining Nasdaq compliance with minimum bid price requirements.read more...

Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration

Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration PR Newswire SACRAMENTO, Calif. and SAN DIEGO, May...

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Sacramento, CA.

Lunai Bioworks Inc.

Bearish Sentiment

<ul class="summary-bullets"><li>Lunai had implemented a 1-for-8 reverse stock split on May 22.</li><li>Nasdaq placed the company under a one-year monitoring period, during which any bid price non-compliance would not qualify for standard compliance processes.</li><li>LNAI generated significant buzz on Stocktwits, with message volumes shooting up by nearly 20,000%&nbsp;</li></ul>Lunai Bioworks (LNAI) generated sharp pre-market buzz on Wednesday, with the shares smashing past 100% after the biotechnology firm announced it had regained compliance with Nasdaq’s minimum bid price requirement, removing a key listing overhang.If the pre-market levels hold after the opening bell, LNAI shares would clock their biggest single-day gains in three months.<h2 class="st-heading-2">LNAI Compliant With Nasdaq’s $1 Requirement</h2>According to an SEC filing, Lunai Bioworks said Nasdaq confirmed that the company regained compliance with the exchange’s minimum bid price requirement, which requires shares to trade at or above $1. Nasdaq had notified the company on April 20 and shared extension letters on May 12, outlining the terms for regaining compliance.Nasdaq also placed Lunai Bioworks under a one-year monitoring period. During that time, if the company falls out of compliance with the bid price rule again, it will not be eligible for a standard compliance plan or extension period. Instead, Nasdaq could issue a delisting notice.<h2 class="st-heading-2">What Actions Did LNAI Take To Regain Compliance?</h2>At a special stockholders meeting held on May 8, shareholders approved a proposal allowing the company to carry out a reverse stock split in the range of 1-for-3 to 1-for-30, with the final ratio to be determined by the board of directors.Following shareholder approval, the board implemented a 1-for-8 reverse stock split that became effective on May 22. The move reduced the company’s outstanding shares from roughly 36.3 million to about 4.5 million. The company previously effected a 1-for-10 reverse stock split on September 30, 2025.<h2 class="st-heading-2">LNAI Bulls Eye $10</h2>Retail sentiment surrounding LNAI on Stocktwits flipped to ‘extremely bullish’ from ‘neutral’ a day earlier, while message volumes surged by a whopping 19,900% in the same time frame.One user highlighted the potential resistance levels, adding that the stock could climb to $10. It is currently trading at around $5.6.<stembedurl>https://stocktwits.com/trading_micro/message/656671004</stembedurl>Another user added that the stock could face compliance challenges if it falls below $3.<stembedurl>https://stocktwits.com/ReaLiLJ/message/656672066</stembedurl>Read also: <a href="https://stocktwits.com/news-articles/markets/equity/bitcoin-miners-face-50b-funding-gap-ai-vaneck/cZK0tjyR7I0">Bitcoin Miners Face Roughly $50B Funding Gap In The Race To Build AI Infrastructure, VanEck Says</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Lunai Bioworks logo is seen displayed on a smartphone screen

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$0.472
Prev Close	$0.6804
Open	$0.6952
Dividend Yield	0.00%
50-Day Moving Average	$1.92
Beta	1.56
Avg. Volume	46,207.55
PE Ratio	-0.54

52-Week High	$13.28
52-Week Low	$0.4615
Market Capitalization	$3.43M
EPS (Annual)	-$1.06
Price to Book	-0.24
Revenue Per Employee	$4,332.67

Feed

News

Sentiment

Earnings

Fundamentals

Info

LNAI Fundamentals